Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000077.xml
Semin Thromb Hemost 2003; 29(6): 557-566
DOI: 10.1055/s-2004-815623
DOI: 10.1055/s-2004-815623
Arterial Thromboembolism in the Pediatric Population
Victoria Price1 , M. Patricia Massicotte2- 1Fellow, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto
- 2Peter Olley Chair in Pediatric Thrombosis, Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada
Further Information
Publication History
Publication Date:
13 January 2004 (online)
ABSTRACT
The most common cause of arterial thromboembolism in the pediatric population is secondary to arterial catheterization. Non-catheter-related arterial thromboembolism is rare. The frequency of this complication has paralleled the advances in pediatric tertiary care that has lead to increasing numbers of children surviving life-threatening primary illnesses. Previously, these events were very rare and children were managed according to adult protocols. It is now known that the pathophysiology of thrombosis in children differs from that of adults and indeed is different for that of various age groups within the pediatric population, therefore requiring a unique diagnostic and therapeutic approach. This review highlights the available published data to support an evidence-based approach to the complication of arterial thromboembolism in the pediatric population, and underscores the urgent need for further randomized controlled trials.
KEYWORDS
Arterial thromboembolism - children - catheters - treatment
REFERENCES
- 1 Andrew M, David M, de Veber G, Brooker L A. Arterial thromboembolic complications in paediatric patients. Thromb Haemost . 1997; 78 715-725
- 2 Randolph A G, Cook D J, Gonzalles C A, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systemic review and meta-analysis of randomized controlled trials. BMJ . 1998; 316 969-975
- 3 Scheer B, Perel A, Pfeiffer U J. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care . 2002; 6 199-204
- 4 Downs J B, Chapman R L, Hawkins F. Prolonged radial artery catheterization. An evaluation of heparinized catheters and continuous irrigation. Arch Surg . 1974; 108 671-673
- 5 American Association of Critical Care Nurses. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. Am J Crit Care . 1993; 2 3-15
- 6 Hoar P F, Wilson R M, Mangano D T. Heparin bonding reduces thrombogenicity of pulmonary artery catheters. N Engl J Med . 1981; 305 993-995
- 7 Butt W, Shann F, McDonnell G, Hudson I. Effect of heparin concentration and infusion rate on the patency of arterial catheters. Crit Care Med . 1987; 15 230-232
- 8 Clifton G D, Branson P, Kelly H J. et al . Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency. Heart Lung . 1991; 20 115-118
- 9 Kulkarni M, Elsner C, Ouellet D, Zeldin R. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter. Can J Surg . 1994; 37 37-42
- 10 de Neef M, Heijboer H, van Woensel B M J, de Haan J R. The efficacy of heparinization in prolonging the patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol . 2002; 19 553-560
- 11 Rais-Bahrami K, Karna P, Dolanski E A. Effect of fluids on life span of peripheral arterial lines. Am J Perinatol . 1990; 7 122-124
-
12 Barrington K. Umbilical artery catheters in the newborn: effects of the position of the catheter. The Cochrane Database of Systemic Reviews, vol. 1. 2003
-
13 Barrington K. Umbilical artery catheters in the newborn: effects of catheter design (end vs side hole) The Cochrane Database of Systemic Reviews, vol. 1. 2003
-
14 Barrington K. Umbilical artery catheters in the newborn: effects of catheter materials. The Cochrane Database of Systemic Reviews, vol. 1. 2003
-
15 Barrington K. Umbilical artery catheters in the newborn: effects of heparin. The Cochrane Database of Systemic Reviews, vol. 1. 2003
- 16 Wesstrom G, Finnstrom O, Stenport G. Umbilical artery catheterization in newborns. Thrombosis in relation to catheter type and position. Acta Paediatr Scand . 1979; 68 575-581
- 17 Jackson J C, Truog W E, Watchko J F, Mack L A, Cyr D R, van Belle G. Efficacy of thromboresistant umbilical artery catheters in reducing aortic thrombosis and related complications. J Pediatr . 1987; 110 102-105
- 18 Boros S J, Thompson T R, Reynolds J W, Jarvis C W, Williams H J. Reduced thrombus formation with silicone elastomere (silastic) umbilical artery catheters. Pediatrics . 1975; 56 981-986
- 19 Bosque E, Weaver L. Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant. J Pediatr . 1986; 108 141-143
- 20 Horgan M, Bartoletti A, Polonsky S, Peters, Manning T, Lamont B. Effect of heparin infusates in umbilical artery catheters on the frequency of thrombotic complications. J Pediatr . 1987; 111 774-778
- 21 Ankola P, Atakent Y. Effect of adding heparin in very low concentrations to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol . 1993; 10 229-232
- 22 David R J, Merten D F, Anderson J C, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther . 1981; 2 117-126
- 23 Stanger P, Heymann M A, Tarnoff H. et al . Complications of cardiac catherization of neonates, infants and children. Circulation . 1974; 50 595-608
- 24 Vitiello R, McCrindle W, Nykanen D, Freedom R, Benson L. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol . 1998; 32 1433-1440
- 25 Kocis K C, Snider A R, Vermillion R P, Beekman R H. Two dimensional and Doppler ultrasound evaluation of femoral arteries in infants after cardiac catheterization. Am J Cardiol . 1995; 75 642-645
- 26 Saxena A, Gupta R, Kumar R K, Kothari S S, Wasir H S. Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheter Cardiovasc Diagn . 1997; 41 400-403
- 27 Bulbul Z R, Galal M O, Mahmoud E. et al . Arterial complications following cardiac catheterization in children less than 10 kg. Asian Cardiovasc Thorac Ann . 2002; 10 129-132
- 28 Freed M, Keane J, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation . 1974; 50 565-569
- 29 Schmidt B, Andrew M. Neonatal thrombotic disease: Prevention, diagnosis and therapy. J Pediatr . 1988; 113 407-410
- 30 Andrew M, Monagle P, de Veber G, Chan A KC. Thromboembolic disease and antithrombotic therapy in newborns. Hematology (Am Soc Hematol Educ Program) . 2001; 358-374
- 31 Ino T, Benson L N, Freedom R M, Barker G A, Zipursky A, Rowe R D. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J . 1988; 115 633-639
- 32 Marsh J L, King W, Barrett C, Fonkalsrud E W. Serious complications after umbilical artery catheterization for neonatal monitoring. Arch Surg . 1975; 110 1203-1208
- 33 Wigger H J, Bransiver B R, Blanc W A. Thromboses due to catheterization in infants and children. J Pediatr . 1970; 76 1-11
- 34 Letts M, Blastorah B, Al-Azzam S. Neonatal gangrene of the extremities. J Pediatr Orthop . 1997; 17 397-401
- 35 Krishnamoorthy K S, Fernandex R J, De Long R G. Paraplegia associated with umbilical artery catheterization in the newborn. Pediatrics . 1976; 58 443-445
- 36 Munoz M E, Roche C, Escriba R, Martinez-Bermejo A, Pascual-Castroviego I. Flaccid paraplegia as complication of umbilical artery catheterization. Pediatr Neurol . 1993; 9 401-403
- 37 Mayer T, Levine M E, Thompson F A. Necrosis of the forearm following radial artery catheterization in a patient with Reye's syndrome. Pediatrics . 1980; 65 141-143
- 38 Kerr G S, Hallahan C W, Giorgano J. et al . Takayasu arteritis. Ann Intern Med . 1994; 120 919-929
- 39 Martini A. Behcet's disease and Takayasu's disease in children. Curr Opin Rheumatol . 1995; 7 449-454
- 40 Brogan P A, Dillon M J. Vasculitis from the pediatric perspective. Curr Rheumatol Rep . 2000; 2 411-416
- 41 Hall S, Barr W, Lie T J. Takayasu arteritis: a study of 32 North American patients. Medicine . 1985; 64 89-99
- 42 Shulman S T, Inocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am . 1995; 42 1205-1222
- 43 Dhillon R, Newton L, Rudd P T, Hall S M. Management of Kawasaki disease in the British Isles. Arch Dis Child . 1993; 69 631-638
- 44 Dajani A S, Bison A L, Chung K L. et al . Diagnostic guidelines for Kawasaki disease. Am J Dis Child . 1990; 144 1218-1219
- 45 Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics . 1979; 63 175-179
- 46 Brogan P A, Bose A, Burgner D C. et al . Kawasaki disease: an evidence based approach to diagnosis, treatment and proposals for future research. Arch Dis Child . 2002; 86 286-290
- 47 Terai M, Shulman S T. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr . 1997; 131 888-893
- 48 Durongpisitkul K, Gururaj V J, Park J M, Martin C F. The prevention of coronary artery aneurysm in Kawasaki disease: a meta- analysis on the efficacy of aspirin and immunoglobin treatment. Pediatrics . 1995; 96 1057-1061
- 49 Newburger J W. Kawasaki disease. Cur Treat Options Cardiovasc Med . 2000; 2 227-236
- 50 Weiss P, Soff G A, Halkin H, Seligsohn U. Decline of protein C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res . 1987; 45 783-790
- 51 Etheridge S P, Tani L Y, Minich L L, Revenaugh R. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. Cathet Cardiovasc Diagn . 1998; 45 264-268
- 52 Williams W G, Pollack J C, Geiss D M, Trussler G A, Fowler R S. Experience with aortic and mitral valve replacement in children. J Thorac Cardiovasc Surg . 1981; 81 326-333
- 53 Williams D, Danielson G, McGoon D, Puga F, Mair D, Edwards W. Porcine heterograft valve replacement in children. J Thorac Cardiovasc Surg . 1982; 84 446-450
- 54 Antunes M J, Vanderdonck K M, Sussman M J. Mechanical valve replacement in children and teenagers. Eur J Cardiothorac Surg . 1989; 3 222-228
- 55 Human D G, Joffe H S, Fraser C B, Barnard C N. Mitral valve replacement in children. J Thorac Cardiovasc Surg . 1982; 83 873-877
- 56 Schaffer M S, Clarke D R, Campbell D N, Madigan C K, Wiggins Jr W J, Wolfe R R. The St. Jude medical cardiac valve and children: role of anticoagulant therapy. J Am Coll Cardiol . 1987; 9 235-239
- 57 Bradley L M, Midgley F M, Watson D C, Geston P R, Scott III P L. Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol . 1985; 56 533-535
- 58 Stewart S, Cianciotta D, Alexson C, Manning J. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic valve cardiac valves. J Thorac Cardiovasc Surg . 1987; 93 551-554
- 59 Solymar L, Rao P S, Mardini M K, Fawzy M E, Guinn G. Prosthetic valves in children and adolescents. Am Heart J . 1991; 121 557-568
- 60 Borkon A M, Soule L, Reitz B A, Gott V L, Gardner T J. Five year follow-up after valve replacement with St. Jude medical valve in infants and children. Circulation . 1986; 74(Suppl I) 110-115
- 61 Milano A, Vouhe P R, Baillot-Vernant F. et al . Late results after left-sided cardiac valve replacement in children. J Thorac Cardiovasc Surg . 1986; 92 218-225
- 62 Woods A, Vargas J, Berri G, Kreutzer G, Meschengieser S, Lazzari M A. Antithrombotic therapy in children and adolescents. Thromb Res . 1986; 42 289-301
- 63 Ries M, Singer H, Hofbeck M. Thrombolysis of a modified Blalock Taussig shunt with recombinant tissue plasminogen activator in newborn infants with pulmonary atresia and ventricular septal defect. Br Heart J . 1994; 72 201-202
- 64 Tsai K T, Chang C H, Lin P J. Modified Blalock Taussig shunt: statistical analysis of potential factors influencing shunt outcome. J Cardiovasc Surg . 1996; 37 149-152
- 65 Gladman G, McCrindle B W, Williams W G, Freedom R M, Benson L N. The modified Blalock Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg . 1997; 114 25-30
- 66 Zahn E M, Chang A C, Aldousany A, Burke R. Emergent stent placement for acute Blalock-Taussig shunt obstruction after stage 1 Norwood surgery. Cathet Cardiovasc Diagn . 1997; 42 191-194
- 67 Ries M, Singer H, Hofbeck M. Thrombolysis of modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect. Br Heart J . 1994; 72 201-202
- 68 Tamisier D, Vouhe P, Vernant F, Leca F, Massot C, Neveux J Y. Modified Blalock-Taussig shunts: results infants less than 3 months of age. Ann Thorac Surg . 1990; 49 797-801
- 69 Mullen J C, Lemermeyer G, Bentley M J. Modified Blalock-Taussig shunts: to heparinize or not to heparinize. Can J Cardiol . 1996; 12 645-647
- 70 Rajani R M, Dalvi B V, Kulkarni H L, Kale P A. Acutely blocked Blalock-Taussig shunt following cardiac catheterization: successful recanalization with intravenous streptokinase. Am Heart J . 1990; 20 1238-1239
- 71 Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax . 1971; 26 240-248
- 72 De Leval R M, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operation. J Thorac Cardiovasc Surg . 1988; 96 682-695
- 73 Gale A W, Danielson G K, McGoon D C, Mair D D, Warnes C A, Driscoll D J. Modified Fontan operation for univentricular heart and complicated congenital lesions. J Thorac Cardiovasc Surg . 1979; 78 831-838
- 74 Cetta F, Feldt R H, O'Leary P W, Mair D D, Warnes C A, Driscoll D J. Improved early morbidity after Fontan operation: the Mayo clinic experience: 1987-1992. J Am Coll Cardiol . 1996; 28 480-486
- 75 Jahangiri M, Ross D B, Redington A N, Lincoln C, Shinebourne E A. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg . 1994; 58 1409-1413
- 76 Monagle P, Cochrane A, McCrindle B, Benson L, Williams W, Andrew M. Thromboembolic complications after Fontan procedures: The role of prophylactic anticoagulation. J Thorac Cardiovasc Surg . 1998; 115 493-498
- 77 Monagle P, Karl T R. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu . 2002; 5 36-47
- 78 Garcia-Gallont R, Bar-Nathan N, Shaharabani E, Yussim A, Shapira R, Zahari I. Hepatic artery thrombosis in pediatric liver transplantion: graft salvage after thrombectomy. Pediatr Transplant . 1999; 3 74-78
- 79 Rela M, Muiesan P, Baker A. et al . Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation . 1996; 61 1355-1357
- 80 Dunn S P, Billmore D F, Falkensein K. et al . Rejection after pediatric liver transplantation is not the limiting factor to survival. J Pediatr Surg . 1994; 29 1141-1143
- 81 Drazan K, Shaked A, Olthoff K M. et al . Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT). Am Surg . 1996; 62 237-240
- 82 McDiarmid S V. Management of the pediatric liver transplant patient. Liver Transpl . 2001; 7 (suppl 1) S77-S86
- 83 Figueras J, Busquets J, Dominguez J. et al . Intra-arterial thrombolysis in the treatment of acute hepatic artery thrombosis after liver transplantation. Transplantation . 1995; 59 1356-1357
- 84 Valdes R, Munoz R, Brancho E, Gordillo G, Velazquez L, Nieto J. Surgical complications of renal transplantation in malnourished children. Transplant Proc . 1994; 26 50-51
- 85 Harmon W E, Stablein D, Alexander S R, Tejani A. Graft thrombosis in pediatric renal transplant recipients. Transplantation . 1991; 51 406-412
- 86 Kalicinski P, Kaminiski A, Prokural A. et al . Surgical complications after kidney transplantation in children. Transplant Proc . 1994; 26 42-43
- 87 Broyer M, Mitsioni A, Gagnadoux M F. et al . Early failures of kidney transplantation: a study of 70 cases from 801 consecutive grafts performed in children and adolescents. Adv Nephrol Necker Hosp . 1993; 22 169-191
- 88 Spirnak J P, Resnick M I. Revascularization of traumatic thrombosis of the renal artery. Surg Gynecol Obstet . 1987; 164 22-26
- 89 Ostuni P A, Lazzarin P, Pengo V, Ruffatti A, Schiavou F, Gambari P. Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis . 1990; 49 184-187
- 90 Harmon W E, Stablein D, Alexander S R, Tejani A. Graft thrombosis in pediatric renal transplant recipients. Transplantation . 1991; 51 406-412
- 91 Haitas B, Baker S G, Meyer T E, Joffe B I, Seftel H C. Natural history and cardiac manifestations of homozygous familial hypercholestrolaemia. Q J Med . 1990; 76 731-740
- 92 Goldstein J, Brown M, Stanbury JB (eds). Metabolic Basis of Inherited Disease. New York: McGraw Hill; 1989
- 93 Rose V, Wilson G, Steiner G. Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygote sibling. J Pediatr . 1982; 100 757-759
- 94 Sorensen K. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest . 1994; 93 50-55
- 95 West R J, Lloyd J K. Hypercholesterolemia in childhood. Adv Pediatr . 1979; 26 1-34
- 96 Mudd S H, Skovby F, Levy H L. et al . The natural history of homocysteinuria due to cystathionine b-synthase deficiency. Am J Hum Genet . 1985; 37 1-31
- 97 Wada Y, Narisawa K, Arakawa T. Infantile type of homocysteinuria with 5,10-methylenetetrahydrofolate reductase deficiency. Monogr Hum Genet . 1978; 9 140-146
- 98 Selhub J, Jacques P F, Wilson P WF, Rush D, Rosenberg L H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA . 1993; 270 2693-2698
- 99 Chauveau P, Chadefaux B, Coude M. et al . Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab . 1992; 18 196-198
- 100 Clarke R. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med . 1991; 324 1149-1155
- 101 Boushey C, Bereford S AA, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA . 1995; 274 1049-1057
- 102 Monagle P, Michelson A D, Bovill E, Andrew M. Antithrombotic therapy in children. Chest . 2001; 119 (suppl 1) 344S-370S
- 103 Richardson M W, Allen G A, Monahan P E. Thrombosis in children: current perspective and distinct challenges. Thromb Haemost . 2002; 88 900-911
- 104 Manco-Johnson M, Grabowski E F, Hellgreen M. et al . Recommendations for tPA thrombolysis in children. Thromb Haemost . 2002; 88 157-158
- 105 Michelson A D, Bovill E, Andrew M. Antithrombotic therapy in children. Chest . 1995; 108 S506-S522
- 106 Wang M, Hays T, Balasa V. et al . Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol . 2003; 25 379-386
- 107 Manco-Johnson M J, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson M L. Combined thrombolytic therapy and anticoagulant therapy for venous thrombosis in children. Pediatrics . 2000; 136 446-453
- 108 Leaker M, Massicotte M P, Brooker L A, Andrew M. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost . 1996; 76 132-134
- 109 Gupta A A, Leaker M, Andrew M. et al . Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr . 2001; 139 682-688
- 110 Hartmann H J, Hussein A, Trowitzch E B, Hennecke K H. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed . 2001; 85 F18-F22